Your browser doesn't support javascript.
loading
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.
Lai, Junyun; Mardiana, Sherly; House, Imran G; Sek, Kevin; Henderson, Melissa A; Giuffrida, Lauren; Chen, Amanda X Y; Todd, Kirsten L; Petley, Emma V; Chan, Jack D; Carrington, Emma M; Lew, Andrew M; Solomon, Benjamin J; Trapani, Joseph A; Kedzierska, Katherine; Evrard, Maximilien; Vervoort, Stephin J; Waithman, Jason; Darcy, Phillip K; Beavis, Paul A.
Afiliación
  • Lai J; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Mardiana S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • House IG; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sek K; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Henderson MA; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Giuffrida L; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Chen AXY; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Todd KL; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Petley EV; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Chan JD; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Carrington EM; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Lew AM; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Solomon BJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Trapani JA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Kedzierska K; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Evrard M; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Vervoort SJ; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Waithman J; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Beavis PA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Nat Immunol ; 21(8): 914-926, 2020 08.
Article en En | MEDLINE | ID: mdl-32424363
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Dendríticas / Linfocitos T / Inmunoterapia Adoptiva / Proteínas de la Membrana / Neoplasias Experimentales Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Dendríticas / Linfocitos T / Inmunoterapia Adoptiva / Proteínas de la Membrana / Neoplasias Experimentales Límite: Animals / Humans Idioma: En Año: 2020 Tipo del documento: Article